Zai Lab (NasdaqGM:ZLAB) shares have drifted steadily lower over the past month, as investors weigh the company’s ongoing growth prospects against a challenging period for biotech stocks. Despite ...
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ: ZLAB; HKEX: 9688), an innovative, commercial-stage biopharmaceutical company, today announced that ...
Given the large stake in the stock by institutions, Zai Lab's stock price might be vulnerable to their trading decisions 51% of the business is held by the top 10 shareholders Ownership research along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback